Efficacy of vunakizumab in patients with moderate-to-severe plaque psoriasis across diverse disease features: a post hoc analysis of a phase-III trial
{{output}}
Background: The efficacy of interleukin-17 inhibitors may be impacted by baseline psoriasis features. Objective: This post hoc analysis aimed t... ...
